Lessons learned from prior PKAN studies as well as other rare neurodegenerative genetic diseases are discussed and the application of the strategies to other rare diseases with neurodegeneration and movement disorders (e.g., other neurodegeneration with brain iron accumulation [NBIA] disorders, lysosomal storage disorders, and other IEMs) is presented. The gene discussed is PANK2; the disease is movement disorder.